山东威高集团医用高分子制品股份有限公司（01066）于2026年1月15日公告更新翌日披露报表，显示公司于当日通过香港交易所回购180,000股H股，占回购前现有已发行股份（不包括库存股份）的约0.004%。本次回购价格区间介乎每股港币5.49至5.52港元，总支付金额约港币99万港元。
回购完成后，公司已发行股份总数维持4,522,332,324股不变，其中不包括库存股份的数量为4,485,844,724股，库存股份为36,487,600股。公司指购回授权由股东于2025年5月27日通过，可购回的股份总数为451,560,392股。截至本次回购，合计已回购29,839,200股，相当于授权当日已发行股份数目的约6.608%。
公司同时确认已遵循香港联合交易所有限公司证券上市规则及其他相关法律规定。公告由公司秘书黄妙玲签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.